Skip to main content
Caplight Logo









SMöLTAP

SMöLTAP

Private
Providence, Rhode IslandHealthcare & Life Scienceshttps://smoltap.com

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$650,000

Company Overview

SMöLTAP operates in Healthcare & Life Sciences and is based in Providence, Rhode Island. Its latest recorded funding round was a Grant round in November 2025.

SMöLTAP is a therapeutic devices company that has developed an innovative positioning cradle designed to secure infants in a consistent position for a lumbar puncture/spinal tap.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

SMöLTAP Comparables

Compare SMöLTAP with similar companies based on industry and business-model similarity.

SMöLTAP comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dandle•LION Medical
73%
The Medi-Kid Co.
67%
Canadian Hospital Specialties
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

SMöLTAP Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
SeedJul 28, 2023
GrantJul 28, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

SMöLTAP Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 38% MoM.

  • Nov 9, 2025

    Monthly visitors grew 305% MoM, reaching 3.8K.

Book a demo to see all signals

For institutional investors. Book with your work email.

SMöLTAP Filings

Explore SEC and related filing metadata, where available.

SMöLTAP filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about SMöLTAP's valuation, stock price, and market status.

Is SMöLTAP a public or private company?

SMöLTAP is a private company.

What is the current stock price of SMöLTAP?

SMöLTAP is a private company, so its shares have no public market price. Caplight tracks SMöLTAP's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SMöLTAP worth (valuation)?

Valuation information for SMöLTAP is not publicly available.

Can I buy SMöLTAP stock?

SMöLTAP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SMöLTAP's last funding round?

SMöLTAP's most recent funding round was Grant on November 19, 2025.

Who are the main investors in SMöLTAP?

Key investors in SMöLTAP include Cherrystone Angel Group, Rhode Island Commerce Corporation, Rhode Island Life Science Hub, The Charles H. Hood Foundation.

Will SMöLTAP IPO soon?

No public IPO plans have been announced for SMöLTAP.

How can I track SMöLTAP secondary market activity?

Caplight tracks bids, offers, and trades in SMöLTAP's shares on secondary markets.

Firmographic Details

HeadquartersProvidence, Rhode Island
Employee Range5
Year Founded2019
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?